Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Titel:
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Auteur:
Paubelle, Etienne Ducastelle-Leprêtre, Sophie Labussière-Wallet, Hélène Nicolini, Franck Emmanuel Barraco, Fiorenza Plesa, Adriana Salles, Gilles Wattel, Eric Thomas, Xavier